Merck's latest earnings call revealed a mix of growth and pain points for the pharmaceutical giant.
16don MSN
Merck’s full-year 2025 revenue guidance fell short of what some analysts were expecting, at a range of $64.1 billion to $65.6 ...
Merck on Tuesday issued full-year 2025 revenue guidance that fell short of Wall Street's expectations. The company said that sales range reflects a decision to halt shipments of Gardasil, a ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback